$62.69 0.3 0.4%
Last Trade - 3:06pm
| Market Cap | £26.43bn |
| Enterprise Value | £29.76bn |
| Revenue | £80.87bn |
| Position in Universe | 345th / 6841 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 22,760 | 40,607 | 48,382 | 60,116 | 74,639 | 111,115 | 118,017 | 123,536 | +37.3% | ||
| +29.9 | +17.8 | +28.3 | +34.8 | +56.3 | +22.9 | -8.16 | +12.6 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Centene Corporation is a multi-national healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. It operates through two segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through government subsidized and commercial programs. Its Specialty Services segment includes companies offering diversified healthcare services and products to its Managed Care segment and other external customers. It provides a range of healthcare products and services, primarily through Medicaid, Medicare and commercial products.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | September 26, 2001 |
| Public Since | December 13, 2001 |
| No. of Shareholders: | 1,120 |
| No. of Employees: | 71,300 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector), |
| Exchange | New York Stock Exchange |
| Shares in Issue | 581,593,041 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 7700 Forsyth Blvd, ST. LOUIS, 63105-1807, United States |
| Web | https://www.centene.com/ |
| Phone | +1 314 7254477 |
| Contact | () |
| Auditors | KPMG LLP |
As of 3:06pm, shares in Centene are trading at $62.69, giving the company a market capitalisation of £26.43bn. This share price information is delayed by 15 minutes.
Shares in Centene are currently trading at $62.69 and the price has moved by -6.01% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Centene price has moved by -37.13% over the past year.
Of the analysts with advisory recommendations for Centene, there are there are currently 5 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Centene is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Centene is scheduled to issue upcoming financial results on the following dates:
Centene does not currently pay a dividend.
Centene does not currently pay a dividend.
Centene does not currently pay a dividend.
To buy shares in Centene you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Centene are currently trading at $62.69, giving the company a market capitalisation of £26.43bn.
Here are the trading details for Centene:
Based on an overall assessment of its quality, value and momentum, Centene is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Centene are currently priced at $62.69. At that level they are trading at 27.65% discount to the analyst consensus target price of 0.00.
Analysts covering Centene currently have a consensus Earnings Per Share (EPS) forecast of 5.203 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Centene. Over the past six months, the relative strength of its shares against the market has been -19.21%. At the current price of $62.69, shares in Centene are trading at -0.17% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Centene PE ratio based on its reported earnings over the past 12 months is 11.02. The shares are currently trading at $62.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Centene's management team is headed by:
Here are the top five shareholders of Centene based on the size of their shareholding:
